抗脂抗体是血症中血栓形成的替代风险因素吗?
Jecko Thachil1, Emmanuel J Favaloro2,3,4,5, Giuseppe Lippi6
1Department of Haematology, Manchester University Hospitals, Manchester, United Kingdom.
Seminars in thrombosis and hemostasis
|July 28, 2023
概括
过渡性抗脂抗体 (aPL),虽然目前没有针对抗脂综合征 (APS) 的诊断,但仍然可能导致血栓形成和怀孕问题. 需要进一步的研究来了解它们的致病机制.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 产科和妇科 产科和妇科
背景情况:
- 抗脂综合征 (APS) 是一种与抗脂抗体 (aPL) 相关的高凝血状态.
- APS呈现出血栓事件或妊娠并发症.
- 目前的APS诊断需要重复aPL测试,因为它们的性质是短暂的.
研究的目的:
- 审查历史和临床数据,支持过渡性aPL的意义.
- 为了突出暂时aPL.PL的致病潜力.
- 倡导对aPL诱导的血栓形成和怀孕发病机制的研究.
主要方法:
- 历史和临床证据的文献综述.
- 病原性机制的分析.
- 在APS中对aPL的当前理解的综合.
主要成果:
- 过渡的aPL存在,虽然不符合诊断标准,但可以是致病的.
- 有证据表明aPL有助于血栓形成和妊娠并发症.
- 暂时aPL致病性背后的机制需要进一步研究.
结论:
- 在 APS 病原体中考虑过渡 aPL 证书.
- 进一步的研究至关重要,以阐明过渡性aPL在血栓形成和怀孕后果中的作用.
- 了解这些机制可能会导致改善APS的诊断和治疗策略.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
755
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
755
Venous Thrombosis I: Introduction
13
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
13
Peripheral Artery Disease I: Introduction
10
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
10
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Endocarditis II: Clinical Features of Infective Endocarditis
14
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
14
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
563
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
563


